Actimyo°
Actimyo° is a medical device with 6 clinical trials. Currently 5 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
1 of 1 finished
0.0%
0 ended early
5
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Continuous Measurement of Activity in Patients With Muscle Pathology and in Control Subjects. ActiSLA Part.
Holter of Movement in Patients With Amyotrophic Lateral Sclerosis.
Exploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility.
Holter of Movement in Patients with SMA Undergoing Treatment.
Holter of Movement in Patients with Multiple Sclerosis in Uncontrolled Environment.
Clinical Trials (6)
Continuous Measurement of Activity in Patients With Muscle Pathology and in Control Subjects. ActiSLA Part.
Holter of Movement in Patients With Amyotrophic Lateral Sclerosis.
Exploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility.
Holter of Movement in Patients with SMA Undergoing Treatment.
Holter of Movement in Patients with Multiple Sclerosis in Uncontrolled Environment.
Holter of Movement in Patients with Multiple Sclerosis in Controlled Environment.
All 6 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 6